285 related articles for article (PubMed ID: 18468378)
1. Changes in prescribing behaviors after implementing drug reimbursement rate reduction policy in Taiwan: implications for the medicare system.
Chu HL; Liu SZ; Romeis JC
J Health Care Finance; 2008; 34(3):45-54. PubMed ID: 18468378
[TBL] [Abstract][Full Text] [Related]
2. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
Liu SZ; Romeis JC
Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
[TBL] [Abstract][Full Text] [Related]
3. Financial incentives and physicians' prescription decisions on the choice between brand-name and generic drugs: evidence from Taiwan.
Liu YM; Yang YH; Hsieh CR
J Health Econ; 2009 Mar; 28(2):341-9. PubMed ID: 19091433
[TBL] [Abstract][Full Text] [Related]
4. Adverse pharmaceutical payment incentives and providers' behaviour: the emergence of GP-owned gateway pharmacies in Taiwan.
Lee YC; Huang KH; Huang YT
Health Policy Plan; 2007 Nov; 22(6):427-35. PubMed ID: 17901065
[TBL] [Abstract][Full Text] [Related]
5. Differences in the cost of antidepressants across state Medicaid programs.
Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
[TBL] [Abstract][Full Text] [Related]
6. Changes in drug utilization following the outpatient prescription drug cost-sharing program--evidence from Taiwan's elderly.
Liu SZ; Romeis JC
Health Policy; 2004 Jun; 68(3):277-87. PubMed ID: 15113639
[TBL] [Abstract][Full Text] [Related]
7. [Changes of drug reimbursement expenses incurred by National Health Fund in Silesian voivodeship in the period of 1999-2004].
Swistak P; Dzielicki M; Janiec R; Błońska-Fajfrowska B
Wiad Lek; 2005; 58(9-10):495-9. PubMed ID: 16529058
[TBL] [Abstract][Full Text] [Related]
8. Drug reimbursement and GPs' prescribing decisions: a randomized case-vignette study about the pharmacotherapy of obesity associated with type 2 diabetes: how GPs react to drug reimbursement.
Verger P; Rolland S; Paraponaris A; Bouvenot J; Ventelou B
Fundam Clin Pharmacol; 2010 Aug; 24(4):509-16. PubMed ID: 19840120
[TBL] [Abstract][Full Text] [Related]
9. Effects of a behaviour independent financial incentive on prescribing behaviour of general practitioners.
Martens JD; Werkhoven MJ; Severens JL; Winkens RA
J Eval Clin Pract; 2007 Jun; 13(3):369-73. PubMed ID: 17518801
[TBL] [Abstract][Full Text] [Related]
10. [Physicians' experience with increased use of individual reimbursement for pharmaceuticals].
Levorsen A; Kristiansen IS; Aasland OG
Tidsskr Nor Laegeforen; 2008 Aug; 128(16):1829-32. PubMed ID: 18787593
[TBL] [Abstract][Full Text] [Related]
11. Resistance-induced antibiotic substitution.
Howard DH
Health Econ; 2004 Jun; 13(6):585-95. PubMed ID: 15185388
[TBL] [Abstract][Full Text] [Related]
12. Financial incentives linked to self-assessment of prescribing patterns: a new approach for quality improvement of drug prescribing in primary care.
Wettermark B; Pehrsson A; Juhasz-Haverinen M; Veg A; Edlert M; Törnwall-Bergendahl G; Almkvist H; Godman B; Granath F; Bergman U
Qual Prim Care; 2009; 17(3):179-89. PubMed ID: 19622268
[TBL] [Abstract][Full Text] [Related]
13. The impact of nonreferral outpatient co-payment on medical care utilization and expenditures in Taiwan.
Chen LC; Schafheutle EI; Noyce PR
Res Social Adm Pharm; 2009 Sep; 5(3):211-24. PubMed ID: 19733822
[TBL] [Abstract][Full Text] [Related]
14. Impact of administrative restrictions on antibiotic use and expenditure in Ontario: time series analysis.
Marshall D; Gough J; Grootendorst P; Buitendyk M; Jaszewski B; Simonyi S; Jivraj F; Macleod S
J Health Serv Res Policy; 2006 Jan; 11(1):13-20. PubMed ID: 16378528
[TBL] [Abstract][Full Text] [Related]
15. Variability within general practitioner prescribing over time.
Bishop N; Maling T
N Z Med J; 2000 Jan; 113(1102):14-6. PubMed ID: 10738495
[TBL] [Abstract][Full Text] [Related]
16. Trends in the use of oral antidiabetic drugs by outpatients in Taiwan: 1997-2003.
Chiang CW; Chiu HF; Chen CY; Wu HL; Yang CY
J Clin Pharm Ther; 2006 Feb; 31(1):73-82. PubMed ID: 16476123
[TBL] [Abstract][Full Text] [Related]
17. Impacts of drug reimbursement reductions on utilization and expenditures of oral antidiabetic medications in Taiwan: an interrupted time series study.
Hsu JC; Lu CY; Wagner AK; Chan KA; Lai MS; Ross-Degnan D
Health Policy; 2014 Jun; 116(2-3):196-205. PubMed ID: 24314624
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
[TBL] [Abstract][Full Text] [Related]
19. Rising drug costs: the impact on dermatology.
Rico MJ
Skin Therapy Lett; 2000; 5(4):1-2,5. PubMed ID: 10785406
[TBL] [Abstract][Full Text] [Related]
20. The determinants of the adoption of pharmaceutical innovation: evidence from Taiwan.
Liu YM; Yang YH; Hsieh CR
Soc Sci Med; 2011 Mar; 72(6):919-27. PubMed ID: 21333432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
